As part of the prestigious Link-J & Yokohama City: Life Sciences Seminar Series, this panel discussion brought together leading experts to examine the complexities and opportunities for Japanese companies within the U.S. pharmaceutical industry. Steven's presentation explored the unique structure, challenges, and evolving dynamics of the U.S. pharmaceutical market. It highlighted the shift from a product-focused model to a patient-centered approach, the growing role of value-based care, and the increasing influence of payors..
Key insights include how consolidation, vertical integration, and new therapy models are redefining the U.S. pharmaceutical market. Attendees learned practical insights into payor-driven drug utilization management, government pricing programs, and the complex gross-to-net impact on profitability. Attendees left with a clearer understanding of how to navigate access, reimbursement, and competitive pressures in a rapidly changing environment.